The Canadian Study leaves no doubt that ingredients that contain processed free glutamic acid (MSG) and free aspartic acid -- known neurotoxins -- are used in baby formula. The fact that neurotoxins are present in baby formula is of particular concern because the blood brain barrier is never fully developed in infants, allowing neurotoxins more accessibility to the brain then would be the case in healthy adults.
The amounts of aspartic acid and glutamic acid found in the formulas analyzed in the Canadian Study have been listed separately in the above schedules. However, in studies using experimental animals, neuroscientists have found that glutamic acid and aspartic acid load on the same receptors in the brain, cause identical brain lesions and neuroendocrine disorders, and act in an additive fashion.
You will note that the level of neurotoxins found in the hypoallergenic formula was greater than the level of neurotoxins found in the other formulas. In reviewing the literature on hypoallergenic formulas, we found short term studies that concluded that hypoallergenic formulas are safe because babies tolerated them and gained weight. However, we have not seen any long term studies on the safety of hypoallergenic formulas. We believe that well designed long term studies would demonstrate that infants raised on hypoallergenic formulas, as compared to infants who are breast fed or fed on non-hypoallergenic formulas, will exhibit more learning disabilities at school age, and/or will exhibit more endocrine disorders such as obesity and reproductive disorders later in life. Long term studies on the effects of hypoallergenic formulas need to be done.
To put these figures in perspective, consider that in an FDA sponsored study dated July, 1992 entitled "Safety of Amino Acids Used in Dietary Supplements," the Federation of American Societies for Experimental Biology concluded, in part, that:
"...it is prudent to avoid the use of dietary supplements of L-glutamic acid by pregnant women, infants, and children.... and...by women of childbearing age and individuals with affective disorders." (MSG is called glutamic acid when used in supplements.)
Consider, also, that a press release dated May 27, 1999, which discussed the European Commission marketing authorization for RotaShield(R) Rotavirus Vaccine stated, in part,
"RotaShield(R) should not be given to infants who are hypersensitive to latex or ... or monosodium glutamate."
Shortly after its introduction, RotaShield(R) Rotavirus Vaccine was taken off the market.
Source:
Infant formula